NexgenRx Announces Share Issuances Under Consulting Agreement

TORONTO, ON / ACCESSWIRE / July 18, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce the issuance of an aggregate of 195,312 common shares at a price of $0.32 in respect of the fourth quarterly equity payment under the …
Jetzt den vollständigen Artikel lesen